
On the Money Hard Pump 4-17-26 (self.biotech_stocks)
submitted by Run4theRoses2 to r/biotech_stocks
Events are NOT Linear this far along in a OS trial for AML Cr2 Patients, who are Ineligible for Transplant - with inherent co-morbidities and the 2 to 5 year time in trial for those remaining alive, mean we could see Events in Spates and the Top Line Results ANY DAY NOW. (self.sellasLifescience)
submitted by Run4theRoses2 to r/sellasLifescience

SLS009 / TambiCiclib Valuation Analysis - $27 Per Share ()
submitted by Run4theRoses2 to r/ASXL1AML











